The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Tag: microbiome

4D pharma plc enters into clinical collaboration agreement with MSD
Pharma & Human Health

4D pharma plc enters into clinical collaboration agreement with MSD

JUN 13, 2018
Microbiome differences between urban and rural populations start soon after birth
Pharma & Human Health

Microbiome differences between urban and rural populations start soon after birth

JUN 6, 2018
Microbiotica Enters into Microbiome Collaboration with Genentech
Finance

Microbiotica Enters into Microbiome Collaboration with Genentech

JUN 6, 2018
Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer
Oncology

Monotherapy Trial Approved; the First Live Biotherapeutic Trial in Cancer

MAY 21, 2018
Thryve Secures $1.4 Million Funding to Expand Personalized Probiotics and Individual Microbiome Testing
Biotics and Supplements

Thryve Secures $1.4 Million Funding to Expand Personalized Probiotics and Individual Microbiome Testing

MAY 16, 2018
Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech
Finance

Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

MAY 9, 2018
FDA Clears 4D Pharma’s IND Application for Blautix
Pharma & Human Health

FDA Clears 4D Pharma’s IND Application for Blautix

MAY 9, 2018
Belgian Microbiome Start-up A-Mansia Announces €13m First Close of Series A Financing
Finance

Belgian Microbiome Start-up A-Mansia Announces €13m First Close of Series A Financing

APR 28, 2018
Inocucor $15.9M Final Close of Series B Financing Brings Series B Total to $54.4M
Finance

Inocucor $15.9M Final Close of Series B Financing Brings Series B Total to $54.4M

APR 19, 2018
Synlogic Announces Registered Direct Offering of Common Stock
Biotics and Supplements

Synlogic Announces Registered Direct Offering of Common Stock

APR 6, 2018
Finch Therapeutics and Takeda Announce Global Collaboration to Develop Microbiome Therapeutics in Inflammatory Bowel Disease (IBD)
Finance

Finch Therapeutics and Takeda Announce Global Collaboration to Develop Microbiome Therapeutics in Inflammatory Bowel Disease (IBD)

APR 5, 2018